Arvee Laboratories India Ltd vs Occl Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Arvee Laboratories (India) Ltd is ₹ 150 as of 18 Mar 15:30 . The P/E Ratio of Arvee Laboratories (India) Ltd changed from 22.8 on March 2021 to 72.8 on March 2025 . This represents a CAGR of 26.14% over 5 yearsThe P/E Ratio of OCCL Ltd changed from 18.5 on March 2025 to 18.5 on March 2025 . This represents a CAGR of 0.00% over 1 years The Market Cap of Arvee Laboratories (India) Ltd changed from ₹ 61.05 crore on March 2021 to ₹ 156.47 crore on March 2025 . This represents a CAGR of 20.71% over 5 yearsThe Market Cap of OCCL Ltd changed from ₹ 397.31 crore on March 2025 to ₹ 397.31 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Arvee Laboratories (India) Ltd for the Dec '25 is ₹ 9.92 crore as compare to the Sep '25 revenue of ₹ 3.68 crore. This represent the growth of 169.57% The revenue of OCCL Ltd for the Dec '25 is ₹ 114.62 crore as compare to the Sep '25 revenue of ₹ 120.62 crore. This represent the decline of -4.97% The ebitda of Arvee Laboratories (India) Ltd for the Dec '25 is ₹ 1.76 crore as compare to the Sep '25 ebitda of ₹ 0.36 crore. This represent the growth of 388.89% The ebitda of OCCL Ltd for the Dec '25 is ₹ 17.06 crore as compare to the Sep '25 ebitda of ₹ 20.21 crore. This represent the decline of -15.59% The net profit of Arvee Laboratories (India) Ltd changed from ₹ 0.94 crore to ₹ 1.83 crore over 7 quarters. This represents a CAGR of 46.33% The net profit of OCCL Ltd changed from ₹ -0.04 crore to ₹ 6.53 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Arvee Laboratories (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of OCCL Ltd changed from 34.98 % on March 2025 to 34.98 % on March 2025 . This represents a CAGR of 0.00% over 1 years .

About Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Limited was incorporated as a Private Limited Company with the name 'Arvee Laboratories (India) Private Limited' on January 27, 2012 in Ahmedabad, Gujarat.
Subsequently, the Company name was changed to Arvee Laboratories (India) Limited upon conversion into a Public Limited Company on September 19, 2017.
Presently, the Company is engaged in manufacturing of specialized chemicals. Initially, the control & management of the Company was with Mr. Bharat Rasiklal Chokshi, Mr Saumil Bharatbhai Chokshi, Mr. Sudhakarbhai Chhotabhai Patel and Mr. Shalin Bharat Chokshi who were the subscribers to the Memorandum of Association.
Since, April 01, 2013 the control & management was completely taken over by Mr. Shalin Sudhakarbhai Patel and Mr. Shalin Bharat Chokshi. The Company started construction of its first plant for Thiophene Derivatives in 2013.

About OCCL Ltd

OCCL Limited was incorporated on April 25, 2022, at Mundra, Kachchh, Gujarat with a Certificate of Incorporation issued by the RoC. The Company belongs to the AG Ventures Group of companies.
The Company's first insoluble sulphur manufacturing facility, (transferred from demerged entity), was set up in 1994 in Dharuhera to manufacture insoluble sulphur, now its flagship product. The Company manufactures commercial grade and battery grade sulphuric acid and oleum at its Dharuhera Plant.
The Company's state-of-the-art manufacturing facilities are located in Dharuhera in Haryana and Mundra in Gujarat. The Company commenced production of Sulphuric Acid in 1978; commenced production capacity of 3,000 MT per annum Insoluble Sulphur in 1994; established a second line of business at Dharuhera in 2005; commenced construction of plant at Mundra in 2009; commissioned the first line of 5500 MTPA at Mundra Plant in 2011; commissioned the second line of insoluble sulphur at Mundra with production capacity of 5500 MTPA in 2012; expanded the additional 11,000 TPA of insoluble sulphur capacity at Mundra in 2016; commissioned the third line of insoluble sulphur with installed capacity of 5500 MTPA at Mundra Plant in 2017; commissioned the fourth line of insoluble sulphur with 5500 MTPA at Mundra in 2018; commissioned the expansion of 5500 MTPA insoluble sulphur at Dharuhera Plant in 2021; commissioned an additional 42000 MTPA capacity of sulphuric acid at Dharuhera Plant in 2022.

FAQs for the comparison of Arvee Laboratories (India) Ltd and OCCL Ltd

Which company has a larger market capitalization, Arvee Laboratories (India) Ltd or OCCL Ltd?

Market cap of Arvee Laboratories (India) Ltd is 164 Cr while Market cap of OCCL Ltd is 425 Cr

What are the key factors driving the stock performance of Arvee Laboratories (India) Ltd and OCCL Ltd?

The stock performance of Arvee Laboratories (India) Ltd and OCCL Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Arvee Laboratories (India) Ltd and OCCL Ltd?

As of March 18, 2026, the Arvee Laboratories (India) Ltd stock price is INR ₹149.49. On the other hand, OCCL Ltd stock price is INR ₹85.19.

How do dividend payouts of Arvee Laboratories (India) Ltd and OCCL Ltd compare?

To compare the dividend payouts of Arvee Laboratories (India) Ltd and OCCL Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.